Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Perimeter Solutions (PRM)

Perimeter Solutions Sa
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:PRM
DateTimeSourceHeadlineSymbolCompany
24/05/202412:30Business WireHarvest déclare la distribution de mai 2024 de Société à capital scindé Grandes pharmaceutiquesNYSE:PRMPerimeter Solutions Sa
15/05/202422:30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:PRMPerimeter Solutions Sa
23/04/202412:30Business WireHarvest déclare la distribution d’avril 2024 de Société à capital scindé Grandes pharmaceutiquesNYSE:PRMPerimeter Solutions Sa
21/03/202411:30Business WireHarvest déclare la distribution de mars 2024 de Société à capital scindé Grandes pharmaceutiquesNYSE:PRMPerimeter Solutions Sa
27/02/202421:07Edgar (US Regulatory)Form 8-K - Current reportNYSE:PRMPerimeter Solutions Sa
22/02/202415:56Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:PRMPerimeter Solutions Sa
22/02/202412:30Business WireHarvest déclare la distribution de février 2024 de Société à capital scindé Grandes pharmaceutiquesNYSE:PRMPerimeter Solutions Sa
22/02/202411:04Edgar (US Regulatory)Form 8-K - Current reportNYSE:PRMPerimeter Solutions Sa
14/02/202419:30Business WireHarvest déclare une distribution spéciale de gains en capital de de catégorie A de Société à capital scindé Grandes pharmaceutiquesNYSE:PRMPerimeter Solutions Sa
24/01/202412:30Business WireHarvest déclare la distribution de janvier 2024 de Société à capital scindé Grandes pharmaceutiquesNYSE:PRMPerimeter Solutions Sa
18/12/202312:30Business WireHarvest déclare la distribution de décembre 2023 de Société à capital scindé Grandes pharmaceutiquesNYSE:PRMPerimeter Solutions Sa
15/12/202321:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PRMPerimeter Solutions Sa
08/12/202321:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PRMPerimeter Solutions Sa
21/11/202322:23Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:PRMPerimeter Solutions Sa
17/11/202312:30Business WireHarvest déclare la distribution de novembre 2023 de Société à capital scindé Grandes pharmaceutiquesNYSE:PRMPerimeter Solutions Sa
09/11/202315:22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:PRMPerimeter Solutions Sa
09/11/202311:08Edgar (US Regulatory)Form 8-K - Current reportNYSE:PRMPerimeter Solutions Sa
17/10/202312:30Business WireHarvest déclare la distribution d’octobre 2023 de Société à capital scindé Grandes pharmaceutiquesNYSE:PRMPerimeter Solutions Sa
19/09/202312:30Business WireHarvest Declares Big Pharma Split Corp. September 2023 DistributionsNYSE:PRMPerimeter Solutions Sa
19/09/202312:30Business WireHarvest déclare les distributions de septembre 2023 de Société à capital scindé Grandes pharmaceutiquesNYSE:PRMPerimeter Solutions Sa
31/08/202322:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:PRMPerimeter Solutions Sa
18/08/202312:30Business WireHarvest déclare la distribution d’août 2023 de Société à capital scindé Grandes pharmaceutiquesNYSE:PRMPerimeter Solutions Sa
09/08/202321:54Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:PRMPerimeter Solutions Sa
03/08/202315:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:PRMPerimeter Solutions Sa
03/08/202311:06Edgar (US Regulatory)Form 8-K - Current reportNYSE:PRMPerimeter Solutions Sa
19/07/202312:30Business WireHarvest déclare la distribution d’juillet 2023 de Société à capital scindé Grandes pharmaceutiquesNYSE:PRMPerimeter Solutions Sa
19/06/202312:30Business WireHarvest déclare les distributions de juin 2023 de Société à capital scindé Grandes pharmaceutiquesNYSE:PRMPerimeter Solutions Sa
18/05/202312:30Business WireHarvest déclare la distribution d’mai 2023 de Société à capital scindé Grandes pharmaceutiquesNYSE:PRMPerimeter Solutions Sa
15/05/202321:47Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:PRMPerimeter Solutions Sa
12/05/202321:17Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NYSE:PRMPerimeter Solutions Sa
 Showing the most relevant articles for your search:NYSE:PRM

Your Recent History